In a recent article for International Pharmaceutical Industry (IPI), Boy Tjoa, Global Director Engineering at Tjoapack, examines how artificial intelligence (AI) and automation are reshaping pharmaceutical supply chains—turning secondary packaging into a strategic enabler of speed, quality, and reliability.
‍

As the industry faces increasing pressure from complex therapies, stricter regulations, and fragile global supply chains, traditional approaches are no longer sufficient. Secondary packaging, once considered a purely operational step, is now recognised as a critical junction where compliance, product integrity, and supply chain performance converge.

Boy highlights how automation is evolving beyond efficiency gains. By reducing variability in repetitive processes such as labelling, serialisation, and inspection, automated systems enhance consistency and support GMP compliance. At the same time, they generate high-quality, structured data—enabling faster batch release, improved traceability, and more robust regulatory oversight.

Building on this foundation, AI introduces a new layer of intelligence. By analysing operational data, AI can optimise production scheduling, predict equipment failures, identify risks early, and improve resource allocation. Rather than replacing human expertise, it strengthens decision-making and allows teams to respond faster and more confidently.

These capabilities are particularly important in today’s environment of smaller batch sizes and increasing product complexity. AI and automation enable greater flexibility, helping packaging operations adapt to changing demand while maintaining efficiency and control.

The article also highlights the growing importance of data visibility and collaboration across the supply chain. Digitised packaging environments allow real-time insights into production and material flow, strengthening trust between partners and enabling more proactive, integrated decision-making.

Ultimately, Boy emphasises that while technology is transforming operations, the human factor remains essential. The most successful organisations are those that combine advanced systems with skilled teams, using technology to enhance—not replace—expertise and collaboration.

As pharmaceutical supply chains continue to evolve, AI and automation are emerging as critical enablers of a more resilient, agile, and patient-centric future.
‍

📖 Read the full article in IPI [p.60 -61].